GlaxoSmithkline is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (80.7%) : intended for respiratory diseases (34.2% of net sales), cardio-vascular diseases (11.4%), central nervous system disorders (7.8%), cancers (3.8%), viral diseases (3,5%), immune system disorders (0.3%), and other (39%);
- OTC and parapharmaceutical medicine (19.3%).
Net sales break down geographically as follows: the United Kingdom (5.8%), the United States (31.9%) and other (62.3%).